Research Alert: CFRA Keeps Hold Opinion On Adss Of Smith & Nephew Plc

CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We adjust our target price by $3 to $27,

MT NewswiresMay 2 15:25

Smith & Nephew Logs Higher Q1 Revenue; FY24 Guidance Affirmed

Smith & Nephew (SN.L) on Wednesday reported a year-over-year increase to its revenue in the first quarter. The medical technology group's revenue for the three months ended March 30 was nearly $1.39 b

MT NewswiresMay 1 14:37

Smith & Nephew Confident in Outlook in All Three of Business Units

Smith & Nephew Confident in Outlook in All Three of Business Units

Dow JonesMay 1 14:11

Smith & Nephew Sees 2024 Underlying Rev Growth of 5.0%-6.0%

Smith & Nephew Sees 2024 Underlying Rev Growth of 5.0%-6.0%

Dow JonesMay 1 14:10

Earnings Flash (SN.L) SMITH & NEPHEW Posts Q1 Revenue $1.39B

02:08 AM EDT, 05/01/2024 (MT Newswires) -- Earnings Flash (SN.L) SMITH & NEPHEW Posts Q1 Revenue $1.39B

MT NewswiresMay 1 14:08

Smith & Nephew 1Q Orthopaedics Rev Up 4.4% on Underlying Basis

Smith & Nephew 1Q Orthopaedics Rev Up 4.4% on Underlying Basis

Dow JonesMay 1 14:08